Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages
Today, the obesity Action Alliance (OAC) and the obesity society (TOS) sent a letter to the US Food and Drug ...
Read more
How GLP-1 Policy Fits Into Trump’s Greenland Strategy, And Five Other Health Tech Developments
What does a pharmaceutical company have to do with U.S. national security? Perhaps more than meets the eye, based on ...
Read more
